Literature DB >> 26269637

Neuronal Atrophy Early in Degenerative Ataxia Is a Compensatory Mechanism to Regulate Membrane Excitability.

James M Dell'Orco1, Aaron H Wasserman1, Ravi Chopra1, Melissa A C Ingram2, Yuan-Shih Hu3, Vikrant Singh4, Heike Wulff4, Puneet Opal3, Harry T Orr2, Vikram G Shakkottai5.   

Abstract

Neuronal atrophy in neurodegenerative diseases is commonly viewed as an early event in a continuum that ultimately results in neuronal loss. In a mouse model of the polyglutamine disorder spinocerebellar ataxia type 1 (SCA1), we tested the hypothesis that cerebellar Purkinje neuron atrophy serves an adaptive role rather than being simply a nonspecific response to injury. In acute cerebellar slices from SCA1 mice, we find that Purkinje neuron pacemaker firing is initially normal but, with the onset of motor dysfunction, becomes disrupted, accompanied by abnormal depolarization. Remarkably, subsequent Purkinje cell atrophy is associated with a restoration of pacemaker firing. The early inability of Purkinje neurons to support repetitive spiking is due to unopposed calcium currents resulting from a reduction in large-conductance calcium-activated potassium (BK) and subthreshold-activated potassium channels. The subsequent restoration of SCA1 Purkinje neuron firing correlates with the recovery of the density of these potassium channels that accompanies cell atrophy. Supporting a critical role for BK channels, viral-mediated increases in BK channel expression in SCA1 Purkinje neurons improves motor dysfunction and partially restores Purkinje neuron morphology. Cerebellar perfusion of flufenamic acid, an agent that restores the depolarized membrane potential of SCA1 Purkinje neurons by activating potassium channels, prevents Purkinje neuron dendritic atrophy. These results suggest that Purkinje neuron dendritic remodeling in ataxia is an adaptive response to increases in intrinsic membrane excitability. Similar adaptive remodeling could apply to other vulnerable neuronal populations in neurodegenerative disease. SIGNIFICANCE STATEMENT: In neurodegenerative disease, neuronal atrophy has long been assumed to be an early nonspecific event preceding neuronal loss. However, in a mouse model of spinocerebellar ataxia type 1 (SCA1), we identify a previously unappreciated compensatory role for neuronal shrinkage. Purkinje neuron firing in these mice is initially normal, but is followed by abnormal membrane depolarization resulting from a reduction in potassium channels. Subsequently, these electrophysiological effects are counteracted by cell atrophy, which by restoring normal potassium channel membrane density, re-establishes pacemaker firing. Reversing the initial membrane depolarization improved motor function and Purkinje neuron morphology in the SCA1 mice. These results suggest that Purkinje neuron remodeling in ataxia is an active compensatory response that serves to normalize intrinsic membrane excitability.
Copyright © 2015 the authors 0270-6474/15/3511293-16$15.00/0.

Entities:  

Keywords:  SCA1; ataxia; atrophy; cerebellum; channel; purkinje neuron

Mesh:

Substances:

Year:  2015        PMID: 26269637      PMCID: PMC4532759          DOI: 10.1523/JNEUROSCI.1357-15.2015

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  68 in total

1.  Cell types, network homeostasis, and pathological compensation from a biologically plausible ion channel expression model.

Authors:  Timothy O'Leary; Alex H Williams; Alessio Franci; Eve Marder
Journal:  Neuron       Date:  2014-05-21       Impact factor: 17.173

Review 2.  Action potentials recorded with patch-clamp amplifiers: are they genuine?

Authors:  J Magistretti; M Mantegazza; E Guatteo; E Wanke
Journal:  Trends Neurosci       Date:  1996-12       Impact factor: 13.837

Review 3.  Clinical features, neurogenetics and neuropathology of the polyglutamine spinocerebellar ataxias type 1, 2, 3, 6 and 7.

Authors:  Udo Rüb; Ludger Schöls; Henry Paulson; Georg Auburger; Pawel Kermer; Joanna C Jen; Kay Seidel; Horst-Werner Korf; Thomas Deller
Journal:  Prog Neurobiol       Date:  2013-02-21       Impact factor: 11.685

4.  Broad therapeutic benefit after RNAi expression vector delivery to deep cerebellar nuclei: implications for spinocerebellar ataxia type 1 therapy.

Authors:  Megan S Keiser; Ryan L Boudreau; Beverly L Davidson
Journal:  Mol Ther       Date:  2013-12-12       Impact factor: 11.454

5.  Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4.

Authors:  R A Ophoff; G M Terwindt; M N Vergouwe; R van Eijk; P J Oefner; S M Hoffman; J E Lamerdin; H W Mohrenweiser; D E Bulman; M Ferrari; J Haan; D Lindhout; G J van Ommen; M H Hofker; M D Ferrari; R R Frants
Journal:  Cell       Date:  1996-11-01       Impact factor: 41.582

6.  Inward-rectifying potassium (Kir) channels regulate pacemaker activity in spinal nociceptive circuits during early life.

Authors:  Jie Li; Meredith L Blankenship; Mark L Baccei
Journal:  J Neurosci       Date:  2013-02-20       Impact factor: 6.167

7.  Fenamates block gap junction coupling and potentiate BKCa channels in guinea pig arteriolar cells.

Authors:  Xin-Zhi Li; Ke-Tao Ma; Bing-Cai Guan; Li Li; Lei Zhao; Zhong-Shuang Zhang; Jun-Qiang Si; Zhi-Gen Jiang
Journal:  Eur J Pharmacol       Date:  2013-02-16       Impact factor: 4.432

8.  Mutations in potassium channel kcnd3 cause spinocerebellar ataxia type 19.

Authors:  Anna Duarri; Justyna Jezierska; Michiel Fokkens; Michel Meijer; Helenius J Schelhaas; Wilfred F A den Dunnen; Freerk van Dijk; Corien Verschuuren-Bemelmans; Gerard Hageman; Pieter van de Vlies; Benno Küsters; Bart P van de Warrenburg; Berry Kremer; Cisca Wijmenga; Richard J Sinke; Morris A Swertz; Harm H Kampinga; Erik Boddeke; Dineke S Verbeek
Journal:  Ann Neurol       Date:  2012-12       Impact factor: 10.422

9.  Mutations in KCND3 cause spinocerebellar ataxia type 22.

Authors:  Yi-Chung Lee; Alexandra Durr; Karen Majczenko; Yen-Hua Huang; Yu-Chao Liu; Cheng-Chang Lien; Pei-Chien Tsai; Yaeko Ichikawa; Jun Goto; Marie-Lorraine Monin; Jun Z Li; Ming-Yi Chung; Emeline Mundwiller; Vikram Shakkottai; Tze-Tze Liu; Christelle Tesson; Yi-Chun Lu; Alexis Brice; Shoji Tsuji; Margit Burmeister; Giovanni Stevanin; Bing-Wen Soong
Journal:  Ann Neurol       Date:  2012-12       Impact factor: 10.422

10.  Compartmentalized calcium transients trigger dendrite pruning in Drosophila sensory neurons.

Authors:  Takahiro Kanamori; Makoto I Kanai; Yusuke Dairyo; Kei-ichiro Yasunaga; Rei K Morikawa; Kazuo Emoto
Journal:  Science       Date:  2013-05-30       Impact factor: 47.728

View more
  52 in total

1.  Neurodegenerative disease: downsizing neurons.

Authors:  Natasha Bray
Journal:  Nat Rev Neurosci       Date:  2015-09-03       Impact factor: 34.870

2.  MTSS1/Src family kinase dysregulation underlies multiple inherited ataxias.

Authors:  Alexander S Brown; Pratap Meera; Banu Altindag; Ravi Chopra; Emma M Perkins; Sharan Paul; Daniel R Scoles; Eric Tarapore; Jessica Magri; Haoran Huang; Mandy Jackson; Vikram G Shakkottai; Thomas S Otis; Stefan M Pulst; Scott X Atwood; Anthony E Oro
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-07       Impact factor: 11.205

3.  New old drug(s) for spinocerebellar ataxias.

Authors:  Visou Ady; Alanna J Watt
Journal:  J Physiol       Date:  2017-01-01       Impact factor: 5.182

4.  Brain atrophy in picornavirus-infected FVB mice is dependent on the H-2Db class I molecule.

Authors:  April M Huseby Kelcher; Pascal A Atanga; Jeffrey D Gamez; Luz M Cumba Garcia; Stephanie J Teclaw; Kevin D Pavelko; Slobodan I Macura; Aaron J Johnson
Journal:  FASEB J       Date:  2017-02-10       Impact factor: 5.191

5.  Loss-of-function BK channel mutation causes impaired mitochondria and progressive cerebellar ataxia.

Authors:  Xiaofei Du; Joao L Carvalho-de-Souza; Cenfu Wei; Willy Carrasquel-Ursulaez; Yenisleidy Lorenzo; Naileth Gonzalez; Tomoya Kubota; Julia Staisch; Timothy Hain; Natalie Petrossian; Michael Xu; Ramon Latorre; Francisco Bezanilla; Christopher M Gomez
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-04       Impact factor: 11.205

6.  Self-assembling vascular endothelial growth factor nanoparticles improve function in spinocerebellar ataxia type 1.

Authors:  Yuan-Shih Hu; Jeehaeh Do; Chandrakanth Reddy Edamakanti; Ameet R Kini; Marco Martina; Samuel I Stupp; Puneet Opal
Journal:  Brain       Date:  2019-02-01       Impact factor: 13.501

7.  Oligonucleotide therapy mitigates disease in spinocerebellar ataxia type 3 mice.

Authors:  Hayley S McLoughlin; Lauren R Moore; Ravi Chopra; Robert Komlo; Megan McKenzie; Kate G Blumenstein; Hien Zhao; Holly B Kordasiewicz; Vikram G Shakkottai; Henry L Paulson
Journal:  Ann Neurol       Date:  2018-08-06       Impact factor: 10.422

Review 8.  Cellular and circuit mechanisms underlying spinocerebellar ataxias.

Authors:  Pratap Meera; Stefan M Pulst; Thomas S Otis
Journal:  J Physiol       Date:  2016-06-12       Impact factor: 5.182

9.  Progressive impairment of cerebellar mGluR signalling and its therapeutic potential for cerebellar ataxia in spinocerebellar ataxia type 1 model mice.

Authors:  Anton N Shuvaev; Nobutake Hosoi; Yamato Sato; Dai Yanagihara; Hirokazu Hirai
Journal:  J Physiol       Date:  2016-09-15       Impact factor: 5.182

Review 10.  Polyglutamine spinocerebellar ataxias - from genes to potential treatments.

Authors:  Henry L Paulson; Vikram G Shakkottai; H Brent Clark; Harry T Orr
Journal:  Nat Rev Neurosci       Date:  2017-08-17       Impact factor: 34.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.